Using an Equivalent Protections Framework to Improve Oversight of International Human Subjects Research

IF 1.3 3区哲学 Q3 ETHICS

Developing World Bioethics Pub Date : 2026-06-19 Epub Date: 2026-05-25 DOI:10.1111/dewb.70036

Liza Dawson, Hunter Jackson Smith

引用次数: 0

Abstract

Current US military international research protocols involving human subjects are reviewed, approved, and overseen by both US and regulatory bodies. In some cases host nation research partners are disadvantaged due to slower processing times and redundant protocol reviews when competing for opportunities to conduct clinical trials. This article considers international legal and regulatory tensions between protecting host nations’ patient-subjects and supporting host nation researchers’ ability to conduct phase 2 and phase 3 clinical trials in support of important military and global health objectives.

查看原文本刊更多论文

利用同等保护框架改进对国际人体受试者研究的监督。

目前涉及人类受试者的美国军事国际研究协议由美国和监管机构审查、批准和监督。在某些情况下，东道国研究伙伴在竞争进行临床试验的机会时，由于处理时间较慢和方案审查冗余而处于不利地位。本文考虑了保护东道国患者受试者与支持东道国研究人员开展支持重要军事和全球卫生目标的2期和3期临床试验的能力之间的国际法律和监管紧张关系。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Developing World Bioethics 医学-医学：伦理

CiteScore

4.50

自引率

4.50%

发文量

审稿时长

>12 weeks

期刊介绍： Developing World Bioethics provides long needed case studies, teaching materials, news in brief, and legal backgrounds to bioethics scholars and students in developing and developed countries alike. This companion journal to Bioethics also features high-quality peer reviewed original articles. It is edited by well-known bioethicists who are working in developing countries, yet it will also be open to contributions and commentary from developed countries'' authors. Developing World Bioethics is the only journal in the field dedicated exclusively to developing countries'' bioethics issues. The journal is an essential resource for all those concerned about bioethical issues in the developing world. Members of Ethics Committees in developing countries will highly value a special section dedicated to their work.